CEBPB and neoplasm: M-MDSCs can further differentiate into tumour-associated macrophages (TAMs) which have an immunosuppressive M2 phenotype (44) that secrete IL-10, express PD-1 and contribute to tumour angiogenesis, and appears to depend on S100A9 expression and signalling acting via C/EBPbeta (39).